Keri Mayers, DO | |
1 Medical Center Dr, Morgantown, WV 26506-1200 | |
(267) 374-2545 | |
Not Available |
Full Name | Keri Mayers |
---|---|
Gender | Female |
Speciality | Colon & Rectal Surgery |
Location | 1 Medical Center Dr, Morgantown, West Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548618028 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 14171 (California) | Secondary |
208C00000X | Colon & Rectal Surgery | 3915 (West Virginia) | Primary |
Entity Name | West Virginia University Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical trials.
For many people who've had cancer, severe pain can persist even after treatment ends.
Congenital heart defects (CHD) are the most common birth defects in humans, affecting 8 per 1000 live births with one third of affected children requiring intervention in early infancy.
Marking the conclusion of the three-day Dubai International Humanitarian Aid and Development (DIHAD) conference Tuesday, conference attendees called for humanitarians to adopt a more coordinated approach to tackling global health needs, the National reports. "Speakers, including health professionals and officials from international organisations, stressed the need to share medical knowledge and innovations during a crisis, citing the recent Haiti earthquake," the newspaper writes.
VasoStitch is developing a percutaneous access-and-closure system for the nonsurgical deployment of large-diameter transcatheter therapeutic devices, such as Transcatheter Aortic Valve Implants (TAVI) and Endovascular Aneurysm Repair (EVAR) devices. The VasoStitch system is designed to reduce procedural complexity and eliminate the need for an "open" surgical procedure.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Keri Mayers, DO 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: () - | Keri Mayers, DO 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (267) 374-2545 |
News Archive
Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical trials.
For many people who've had cancer, severe pain can persist even after treatment ends.
Congenital heart defects (CHD) are the most common birth defects in humans, affecting 8 per 1000 live births with one third of affected children requiring intervention in early infancy.
Marking the conclusion of the three-day Dubai International Humanitarian Aid and Development (DIHAD) conference Tuesday, conference attendees called for humanitarians to adopt a more coordinated approach to tackling global health needs, the National reports. "Speakers, including health professionals and officials from international organisations, stressed the need to share medical knowledge and innovations during a crisis, citing the recent Haiti earthquake," the newspaper writes.
VasoStitch is developing a percutaneous access-and-closure system for the nonsurgical deployment of large-diameter transcatheter therapeutic devices, such as Transcatheter Aortic Valve Implants (TAVI) and Endovascular Aneurysm Repair (EVAR) devices. The VasoStitch system is designed to reduce procedural complexity and eliminate the need for an "open" surgical procedure.
› Verified 3 days ago